Longevity medicine programme

Longevity medicine programme has been studied in 1 paper since 2026: 1 observational study in people; 1 in the past year. The newest paper, Oct 10, 2026: “Evidence for longevity medicine: a retrospective cohort study of multi-domain health improvement in a structured preventive health programme”.

Exposure

1 paper studies it5 findingsUpdated

See all 1 papers on longevity medicine programme

At a glance

The findings reach people, from one lab or study. 1 lab in 1 country.

“Lipid markers improved, including reductions in LDL cholesterol, ApoB, and triglycerides (all p < 0.001).”
Evidence for longevity medicine: a retrospective cohort study of multi-domain health improvement in a structured preventive health programmeLongevity2026doi:10.1080/30653495.2026.2743528

None of its findings points the other way.

Humans: a single group. Cells, worms or flies and mice: nothing yet.
  • 1 lab in 1 country
  • Humans1

What did studies of longevity medicine programme find?

5

Studies of longevity medicine programme measured 5 outcomes, among them visceral adipose tissue, HbA1c and C-reactive protein.

Visceral adipose tissue

downin humans1

1 study
  1. Longevity medicine programme is linked with lower visceral adipose tissue in humans (paired comparison of baseline and follow-up assessments, uncontrolled).

    Humanspaired comparison of baseline and follow-up assessments, uncontrolledvisceral adipose tissuen = 1,122

More on Visceral adipose tissue

HbA1c

downin humans1

1 study
  1. Longevity medicine programme is linked with lower HbA1c in humans (paired comparison of baseline and follow-up assessments, uncontrolled).

    Humanspaired comparison of baseline and follow-up assessments, uncontrolledn = 5,394

More on HbA1c

C-reactive protein

downin humans1

1 study
  1. Longevity medicine programme is linked with lower C-reactive protein in humans (paired comparison of baseline and follow-up assessments, uncontrolled).

    Humanspaired comparison of baseline and follow-up assessments, uncontrolledn = 5,394

More on C-reactive protein

LDL cholesterol

downin humans1

1 study
  1. Longevity medicine programme is linked with lower LDL cholesterol in humans (paired comparison of baseline and follow-up assessments, uncontrolled).

    Humanspaired comparison of baseline and follow-up assessments, uncontrolledn = 5,394

More on LDL cholesterol

VO2MAX

upin humans1

1 study
  1. Longevity medicine programme is linked with better VO2MAX in humans (paired comparison of baseline and follow-up assessments, uncontrolled).

    Humanspaired comparison of baseline and follow-up assessments, uncontrolledn = 841

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 1Nov 2026: 01 paper in 12 months